Showing 7941-7950 of 10728 results for "".
Levia Introduction
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/levia-introduction-/19428/Levia technology overview, product demonstration and product insights from Lerner Medical Devices team members. Levia®, from Lerner Medical, provides Personal Targeted Phototherapy® for the self-treatment of psoriasis in the privacy and convenience of a patient's home. Levia incorporates easy to usHoya ConBio - Vascular Lesions
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hoya-conbio-vascular-lesions/19454/Vascular Lesions that aren't successfully removed by other treatments are usually successfully removed with the Medlite Laser. Instructions and ideal settings for the laser are discussed.Dr. Ross Discusses Experience with Gemini Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-ross-discusses-experience-with-gemini-laser/19470/“There are a lot of new technologies out there, but one of the tried-and-true technologies is KTP laser and the long-pulse YAG laser. And the Gemini fits the bill for both of those wavelengths. So in a sense the Gemini is a time-tested product. It has served us well at our clinic, both at the NavyEducating NPs and PAs
https://practicaldermatology.com/programs/practical-dermatology/educating-nps-and-pas/39884/Jennifer Cather, MD, and Melodie Young ASN, RN, discuss recent consensus statements from the Genital Psoriasis Wellness Consortium, and Scott Boswell, MD, joins Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, to discuss his boot camp for nurse practitioners and phyPromising Therapies on the Atopic Dermatitis Horizon
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37178/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, previews important potential developments in the atopic dermatitis pipelineISDPA: Dr. Bhatia on JAK Inhibitors
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-jak-inhibitors/27064/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks about his presentation on JAK inhibitors at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Connections for the Future of Dermatology
https://practicaldermatology.com/videos/skin-minute/connections-for-the-future-of-dermatology/54688/Frederick Beddingfield, MD, PhD, recaps the Dermatology Summit 2026, a meeting to connect innovators and investors in the field of dermatology.DWTV Extra: Raising Awareness of GPP
https://practicaldermatology.com/videos/dermwire-tv/dwtv-extra-raising-awareness-of-gpp/56366/Shannon Trotter, DO, discusses the importance of awareness of generalized pustular psoriasis (GPP) and targeting IL-36, as well as GPP Awareness Day in August.DWTV Extra: Rocatinlimab Trials
https://practicaldermatology.com/videos/dermwire-tv/dwtv-extra-rocatinlimab-trials/39044/Clinical investigator Emma Guttman-Yassky, MD, PhD, discusses two sets of data presented at the European Academy of Dermatology and Venereology (EADV) Congress 2025. The phase 3 ROCKET-Ignite Trial evaluated the efficacy and safety of OX40-receptor targeting with rocatinlimab in moderate-to-severe aOrigins of AD: Recent Advances
https://practicaldermatology.com/issues/april-2025/origins-of-ad-recent-advances/35586/This paper reviews a study by Yadev et al. and further investigates the role of transient receptor potential ankyrin 1 (TRPA1) in the pathogenesis of atopic dermatitis (AD).